Lv11
88 积分 2024-01-22 加入
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
1小时前
已完结
Adagrasib for KRASG12C mutated advanced non-small-cell lung cancer
1小时前
已完结
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
1个月前
已完结
The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non–small Cell Lung Cancer
3个月前
已完结
KRAS mutations predict response to EGFR inhibitors
3个月前
已完结
KRAS G12C突变的非小细胞肺癌患者的基因突变谱及临床病理学特征的单中心回顾性研究
3个月前
已完结
Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically Resected Non-Small Cell Lung Cancer
3个月前
已关闭
Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease
4个月前
已完结
皖公网安备34019202002308
